Collectively, these data suggest that CM-272 induces drug metabolic processes while impeding DNA integrity, tumor growth, and most importantly, IGF2-associated PI3K-AKT signaling of HB tumor cells. The gene discussed is AKT1; the disease is hemoglobin measurement.